Cellular binding, uptake and biotransformation of silver nanoparticles in human T lymphocytes

Nat Nanotechnol. 2021 Aug;16(8):926-932. doi: 10.1038/s41565-021-00914-3. Epub 2021 May 13.

Abstract

Our knowledge of uptake, toxicity and detoxification mechanisms as related to nanoparticles' (NPs') characteristics remains incomplete. Here we combine the analytical power of three advanced techniques to study the cellular binding and uptake and the intracellular transformation of silver nanoparticles (AgNPs): single-particle inductively coupled mass spectrometry, mass cytometry and synchrotron X-ray absorption spectrometry. Our results show that although intracellular and extracellularly bound AgNPs undergo major transformation depending on their primary size and surface coating, intracellular Ag in 24 h AgNP-exposed human lymphocytes exists in nanoparticulate form. Biotransformation of AgNPs is dominated by sulfidation, which can be viewed as one of the cellular detoxification pathways for Ag. These results also show that the toxicity of AgNPs is primarily driven by internalized Ag. In fact, when toxicity thresholds are expressed as the intracellular mass of Ag per cell, differences in toxicity between NPs of different coatings and sizes are minimized. The analytical approach developed here has broad applicability in different systems where the aim is to understand and quantify cell-NP interactions and biotransformation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biotransformation
  • Humans
  • Jurkat Cells
  • Metal Nanoparticles* / chemistry
  • Metal Nanoparticles* / therapeutic use
  • Silver* / chemistry
  • Silver* / pharmacokinetics
  • Silver* / pharmacology
  • T-Lymphocytes / metabolism*

Substances

  • Silver